# Healthpeak Properties, Inc.: Form 10-Q for the period ended Jun 30, 2016

- Company: [Healthpeak Properties, Inc.](/companies/doc.md) (CIK 765880)
- Form: 10-Q
- Filed: 2016-08-09
- Accepted by EDGAR: Aug 9, 2016, 08:34 ET
- Period: 2016-06-30
- Accession: 0001558370-16-007721
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/765880/000155837016007721/hcp-20160630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/765880/000155837016007721/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-04-01 to 2016-06-30 | $662.2m | us-gaap:Revenues |
| Revenue | 6 months, 2016-01-01 to 2016-06-30 | $1.30bn | us-gaap:Revenues |
| Interest expense | 3 months, 2016-04-01 to 2016-06-30 | $121.3m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2016-01-01 to 2016-06-30 | $243.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-04-01 to 2016-06-30 | −$2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2016-01-01 to 2016-06-30 | $51.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-04-01 to 2016-06-30 | $301.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2016-01-01 to 2016-06-30 | $417.8m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2016-04-01 to 2016-06-30 | 471,425,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2016-01-01 to 2016-06-30 | 466,777,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2016-01-01 to 2016-06-30 | $666.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2016-01-01 to 2016-06-30 | $222.5m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months, 2016-01-01 to 2016-06-30 | $537.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2016-01-01 to 2016-06-30 | $3.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2016-06-30 | $116.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2016-06-30 | $21.12bn | us-gaap:Assets |
| Total liabilities | at 2016-06-30 | $11.44bn | us-gaap:Liabilities |
| Long-term debt | at 2016-06-30 | $10.66bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2016-06-30 | $9.28bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 98,678 characters.

*All references in this report to “HCP,” “we,” “us” or “our” mean HCP, Inc., together with its consolidated subsidiaries.*

### Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Quarterly Report, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 and Part II, Item 1A. “Risk Factors” in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2016, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:

- HCR ManorCare, Inc.’s (“HCRMC”) ability to meet its contractual obligations under the HCRMC lease amendment and risks related to the impact of the United States (“U.S.”) Department of Justice lawsuit against HCRMC and other legal proceedings involving HCRMC, including the possibility of larger than expected litigation costs, adverse results and related developments;
- our reliance on a concentration of a small number of tenants and operators for a significant portion of our revenues, with our concentration in Brookdale increasing after consummation of the spin-off ;
- the financial condition of our tenants, operators and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings, which results in uncertainties regarding our ability to continue to realize the full benefit of such tenants’ and operators’ leases and borrowers’ loans;
- the ability of our tenants, operators and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;
- competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases;
- competition for skilled management and other key personnel;
- availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;
- our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing tenant or operator upon default;
- the risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners’ financial condition and continued cooperation;
- our ability to achieve the benefits of investments within expected time frames or at all, or within expected cost projections;
- the potential impact on us, our tenants, operators and borrowers from current and future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;
- the effect on our tenants and operators of legislation and other legal requirements, including licensure, certification and inspection requirements, and laws addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements;
- changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations, of our tenants and operators;
- volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in our credit ratings, and the value of our common stock, and other conditions that may adversely impact our ability to fund our obligations or consummate transactions, or reduce the earnings from potential transactions;
- changes in global, national and local economic conditions, and currency exchange rates;
- our ability to manage our indebtedness level and changes in the terms of such indebtedness;
- our ability to maintain our qualification as a real estate investment trust (“REIT”);
- the ability of HCP and Quality Care Properties, Inc. (“QCP”) to complete the pending spin-off of QCP on the currently contemplated timeline or at all; and
- the ability of HCP and QCP to complete financings related to the spin-off transaction on acceptable terms on the currently contemplated timeline or at all.

We do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

- Executive Summary
- 2016 Transaction Overview
- Dividends
- Results of Operations
- Liquidity and Capital Resources
- Contractual Obligations
- Off-Balance Sheet Arrangements
- Inflation
- Non-GAAP Financial Measures Reconciliations
- Critical Accounting Policies
- Recent Accounting Pronouncements

### Executive Summary

HCP, Inc., a Standard & Poor’s (“S&P”) 500 company, invests primarily in real estate serving the healthcare industry in the United States. We are a Maryland corporation organized in 1985 and qualify as a self-administered REIT. We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At June 30, 2016, our portfolio of investments, including properties in our unconsolidated joint ventures, consisted of interests in 1,191 properties.

We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are: (i) to acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple business segments and geographic locations (including Europe), (ii) to align ourselves with leading healthcare companies, operators and service providers, which over the long-term should result in higher relative rental rates, net operating cash flows and appreciation of property values, (iii) to allocate capital targeting a balanced portfolio between longer-term escalating triple-net leases with high-quality tenants, and operating businesses with shorter-term leases in our medical office and life science segments, (iv) to maintain adequate liquidity with long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles and (v) to continue to manage our balance sheet with a targeted financial leverage of 40% relative to our assets.

We believe that our longer-term escalating triple-net leases with larger tenants and operators having scale enhance the quality, stability and growth of our rental income. Further, we believe many of our existing properties hold the potential for increased future cash flows as they are well maintained and in desirable locations within markets where the creation of new supply is limited by the lack of available sites and the difficulty of obtaining the necessary licensing, other approvals and/or financing. Our strategy for maximizing the benefits from these opportunities is to: (i) work with new or existing tenants and operators to address their space and capital needs, and (ii) provide high-quality property management services in order to motivate tenants to renew, expand or relocate into our properties.

The delivery of healthcare services requires real estate and, as a result, tenants and operators depend on real estate, in part, to maintain and grow their businesses. We believe that the healthcare real estate market provides investment opportunities due to the: (i) compelling long-term demographics driving the demand for healthcare services, (ii) specialized nature of healthcare real estate investing and (iii) ongoing consolidation of the fragmented healthcare real estate sector.

While we emphasize healthcare real estate ownership, we may also provide real estate secured financing to, or invest in equity or debt securities of, healthcare operators or other entities engaged in healthcare real estate ownership. We may also acquire all or substantially all of the securities or assets of other REITs, operating companies or similar entities where such investments would be consistent with our investment strategies. We may co-invest alongside institutional or development investors through partnerships or limited liability companies.

We monitor, but do not limit, our investments based on the percentage of our total assets that may be invested in any one property type, investment vehicle or geographic location, the number of properties that may be leased to a single tenant or operator, or loans that may be made to a single borrower. In allocating capital to our multiple segments, we target opportunities with the most attractive risk/reward profile for our portfolio as a whole. We may take additional measures to mitigate risk, including diversifying our investments (by sector, geography, tenant or operator), structuring transactions as master leases, requiring tenant or operator insurance and indemnifications, and obtaining credit enhancements in the form of guarantees, letters of credit or security deposits.

Our REIT qualification requires us to distribute at least 90% of our REIT taxable income (excluding net capital gains); therefore, we do not retain capital. As a result, we regularly access the public equity and debt markets to raise the funds necessary to finance acquisitions and debt investments, develop and redevelop properties, and refinance maturing debt.

We maintain a disciplined balance sheet by actively managing our debt to equity levels and maintaining multiple sources of liquidity, such as our revolving line of credit facility, access to capital markets and secured debt lenders, relationships with current and prospective institutional joint venture partners, and our ability to divest assets. Our debt obligations are primarily long-term fixed rate with staggered maturities, which reduces the impact of rising interest rates on our operations.

We finance our investments based on our evaluation of available sources of funding. For short-term purposes, we may utilize our revolving line of credit facility or arrange for other short-term borrowings from banks or other sources. We arrange for longer-term financing by offering debt and equity securities, placing mortgage debt and obtaining capital from institutional lenders and joint venture partners.

### 2016 Transaction Overview

### HCR ManorCare, Inc.

#### Spin-Off of Real Estate Portfolio

In May 2016, we announced our intention to spin off interests in 338 properties (including 17 non-strategic properties, of which we expect seven to be sold by the end of 2016 and the remaining 10 to be sold in the first quarter of 2017), primarily comprised of our HCRMC direct financing lease (“DFL”) investments, and equity investment in HCRMC (the “Spin-Off”). Quality Care Properties, Inc. (formerly HCP SpinCo, Inc.) will be an independent, publicly-traded, self-managed and self-administrated company. QCP will elect and intends to qualify as a REIT. The Spin-Off is expected to be effectuated through a pro rata special distribution of QCP’s common shares to HCP stockholders and will not qualify as a tax-free spin-off for U.S. federal income tax purposes. The transaction is subject to certain conditions, including the filing and approval of QCP’s common stock to be listed on the New York Stock Exchange, customary third party consents, the U.S. Securities and Exchange Commission (the “SEC”) declaring effective a registration statement for the QCP common shares to be distributed, and approval and declaration of the distribution by our Board of Directors. The transaction is expected to be completed in the fourth quarter of 2016. We may, at any time and for any reason until the proposed transaction is complete, abandon, modify or change the terms of the Spin-Off. There can be no assurance as to whether or when the Spin-Off will occur. QCP filed its initial Registration Statement on Form 10 on June 17, 2016 and Amendment No. 1 to its Registration Statement on Form 10 on August 9, 2016.

#### Second Quarter Operating Performance

For the second quarter of 2016, HCRMC reported normalized EBITDAR (defined as earnings before interest, taxes, depreciation and amortization, and rent) of $132 million, bringing the year-to-date total to $263 million. On a year-over-year basis, normalized EBITDAR decreased $14 million, or 10% for the quarter, and decreased $41 million or 13% year-to-date, primarily due to a weaker flu season, continued pressure from payor mix shift and shorter lengths of stay. HCRMC’s normalized fixed charge coverage ratio for the trailing twelve months ended June 30, 2016 was 1.03x and for the trailing three months ended June 30, 2016 was 1.08x.

HCRMC ended the quarter with $174 million of cash and cash equivalents and continues to be current on its obligations under the amended master lease we entered into with HCRMC in March 2015.

#### First Quarter Operating Performance

For the first quarter of 2016, HCRMC reported normalized EBITDAR of $131 million, which was up $22 million, or 20% sequentially, driven by a 110 basis point increase in core post-acute/skilled nursing occupancy. On a year-over-year basis, normalized EBITDAR decreased $27 million, or 17%, primarily due to a weaker flu season, continued pressure from payor mix shift, and shorter lengths of stay, as well as transaction costs and operational disruption from the non-strategic asset sales. HCRMC’s normalized fixed charge coverage ratio for the trailing twelve months ended March 31, 2016 was 1.06x and for the trailing three months ended March 31, 2016 was 1.11x.

#### Transaction Activity

During the six months ended June 30, 2016, we completed 11 of our planned 50 non-strategic asset sales, generating proceeds of $62 million, bringing total anticipated sales proceeds from all 50 assets to $350 million. Of the 17 remaining non-strategic facilities, seven are expected to close by the end of 2016 and 10 are expected to be sold in the first quarter of 2017. Contracts have been entered into with third party purchasers with respect to the sale of 10 of the 17 properties. In addition, we completed the final transfer of the nine assets that were part of the HCRMC master lease amendment representing $275 million of value received in the fee ownership of these recently built post-acute assets, by acquiring the remaining two assets for $92 million during the three months ended March 31, 2016.

In February 2016, we acquired a new 64-bed memory care facility in Easton, Pennsylvania for $15 million that opened in January 2016, which is located adjacent to our existing post-acute asset. The facility was developed by HCRMC and was added to its master lease with a term of 16 years.

#### Accounting and Income Tax Update

We acquired the HCRMC DFL investments in 2011 through an acquisition of a C-Corporation, which was subject to federal and state built-in gain tax, if all the assets were sold within 10 years, of up to $2 billion. At the time of the acquisition, we intended to hold the assets for at least 10 years, at which time the assets would no longer be subject to the built-in gain tax.

In December 2015, the U.S. Federal Government passed legislation which permanently reduced the holding period, for federal tax purposes, to five years. We satisfied the five year holding period requirement in April 2016. In June 2016, the U.S. Department of the Treasury issued proposed regulations that would change the holding period back to 10 years, but effective only for conversion transactions after August 8, 2016. As currently proposed, these regulations will not impact our properties in the HCRMC DFL, as the HCRMC conversion transaction occurred on April 7, 2011. However, certain states still require a 10-year holding period and, as such, the assets are still subject to state built-in gain tax.

As of March 31, 2016, we determined that we may sell assets during the next five years and, therefore, recorded a deferred tax liability of approximately $49 million representing our estimated exposure to state built-in gain tax.

See Notes 1, 5, 7, 11 and 17 to the Consolidated Financial Statements for additional discussion of HCRMC, which information is incorporated by reference herein.

### Investment Transactions

In January 2016, we acquired a portfolio of five private pay senior housing communities with 364 units and one skilled nursing facility with 120 beds for $95 million. All of the communities were developed within the past two years and are triple-net leased to four regional operators.

In May 2016, we announced that we entered into definitive agreements to acquire a portfolio of seven private pay senior housing communities for $186 million, including the assumption of $75 million of debt maturing in 2044 at a 4.0% interest rate. Consisting of 526 assisted living and memory care units, the portfolio will be managed by Senior Lifestyle Corporation in a 100% owned RIDEA structure which is permitted by the Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”) at closing. We anticipate that the transaction will close during the second half of 2016.

In July 2016, we acquired two Class A life science buildings totaling 136,000 square feet and a four-acre parcel of land in San Diego, California for $49 million.

### Developments

Through August 8, 2016, we have pre-leased approximately 50% of The Cove Phase I, which consists of two Class A buildings totaling up to 250,000 square feet, expected to be delivered in the third quarter of 2016. In response to Phase I leasing success and continued strong demand from life science users in South San Francisco, in February 2016, we commenced the $185 million development, The Cove Phase II, which adds two Class A buildings totaling up to 230,000 square feet expected to be delivered by the third quarter of 2017.

In June 2016, we commenced a $62 million multi-building development project encompassing 301,000 square feet at our Ridgeview Business Park in Poway, California, which is 50% pre-leased. The project includes a $32 million build-to-suit totaling 152,000 square feet for an existing tenant and is expected to be completed in 2018 as part of a larger leasing transaction.

### Disposition Transactions

During the six months ended June 30, 2016, we sold five post-acute/skilled nursing and two senior housing facilities for $130 million, a life science facility for $74 million, two medical office buildings for $19 million and a senior housing facility for $6 million and recognized total gain on sales of $120 million.

In June 2016, we received $51 million from the monetization of two senior housing development loans, recognizing $15 million of incremental interest income, which represents our participation in the appreciation of the underlying real estate assets.

In January 2016, we entered into a sale agreement for purchase options that were exercised on eight life science facilities in South San Francisco, California, to be sold in two tranches for $311 million and $269 million, respectively. The transactions are expected to close in the second half of 2016 for the first tranche and 2018 for the second tranche.

In May 2016, we entered into a master contribution agreement to contribute our ownership interest in joint venture entities that own and operate senior housing properties in a RIDEA structure (“RIDEA II”) to an unconsolidated joint venture owned by HCP and an investor group led by Columbia Pacific Advisors, LLC (“CPA”) (the “HCP/CPA JV”). In return, we will receive $109 million in cash proceeds from the HCP/CPA JV, a $636 million note receivable (“Note”) and retain an approximately 40% beneficial interest in RIDEA II. This transaction, upon completion, would result in us deconsolidating the net assets of RIDEA II because we will not direct the activities that most significantly impact the venture. We further expect that the members will recapitalize RIDEA II, at which time we expect to receive cash proceeds in payment against the Note. The closing of these transactions is expected to occur in 2016 and remains subject to regulatory and third party approvals and other customary closing conditions.

### Financing Activities

During the three months ended June 30, 2016, we prepaid $200 million of maturing mortgage debt with a blended interest rate of 6.6%. We ended the quarter with $0.9 billion drawn on our revolving line of credit facility and $1.1 billion of remaining capacity.

In July 2016, we exercised a one-year extension option on our £137 million ($184 million at June 30, 2016), four-year unsecured term loan that was entered into on July 30, 2012 (the “2012 Term Loan”). Based on our credit ratings at June 30, 2016, the 2012 Term Loan accrues interest at a rate of British pound sterling (“GBP”) LIBOR plus 1.40%.

In February 2016, we refinanced $500 million of maturing unsecured debt using proceeds from our December 2015 offering of senior unsecured notes.

### Dividends

On July 28, 2016, we announced that our Board of Directors declared a quarterly common stock cash dividend of $0.575 per share. The common stock dividend will be paid on August 23, 2016 to stockholders of record as of the close of business on August 8, 2016.

### Results of Operations

We evaluate our business and allocate resources among our business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the medical office segment, the Company invests through the acquisition and development of medical office buildings (“MOBs”), which generally require a greater level of property management. Otherwise, the Company primarily invests, through the acquisition and development of real estate, in single tenant and operator properties and debt issued by tenants and operators in these sectors. We evaluate performance based upon (i) property net operating income from continuing operations (“NOI”), (ii) adjusted NOI (cash NOI), and (iii) adjusted NOI, including the Company’s pro rata share of unconsolidated joint ventures, plus interest income (“Portfolio Income”) of the combined investments in each segment.

### Non-GAAP Financial Measures

#### Net Operating Income (“NOI”)

NOI and adjusted NOI are not U.S. generally accepted accounting principles (“GAAP”), or non-GAAP, supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as rental and related revenues, including tenant recoveries, resident fees and services, and income from DFLs, less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 13 to the Consolidated Financial Statements. Management believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (“non-cash adjustments”). Adjusted NOI is oftentimes referred to as “cash NOI.” We use NOI and adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and to evaluate our same property portfolio (“SPP”), as described below. We believe that net income (loss) is the most directly comparable U.S. generally accepted accounting principles (“GAAP”) measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, our definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating NOI. For a reconciliation of NOI and adjusted NOI to Portfolio Income (our segment measure), and other relevant disclosures by segment, refer to our Segment Analysis below. For a reconciliation of Portfolio Income to net income (loss) by segment, refer to Note 13 to the Consolidated Financial Statements.

Operating expenses generally relate to leased medical office and life science properties and senior housing RIDEA properties. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

#### Same Property Portfolio

SPP NOI and adjusted NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented, excluding assets held for sale. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) control(s) the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. SPP adjusted NOI excludes the effects of foreign exchange rate movements by using the average current period exchange rate to translate from British pound sterling (“GBP”) into U.S. dollar (“USD”) for the comparison periods. A property is removed from our SPP when it is sold, placed into redevelopment or changes its reporting structure. For a reconciliation of SPP to Portfolio Income and other relevant disclosures by segment, refer to our Segment Analysis below.

#### Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of depreciable property, including any current and deferred taxes directly associated with sales of depreciable property, impairments of, or related to, depreciable real estate, plus real estate and other depreciation and amortization, and adjustments to compute our share of FFO from joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours.

In addition, we present FFO before the impact of severance-related charges, litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets, foreign currency remeasurement losses (gains) and transaction-related items (“FFO as adjusted”). Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors and other interested parties in the evaluation of our performance as a REIT. This non-GAAP supplemental measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (loss) (determined in accordance with GAAP) or NAREIT FFO. For a reconciliation of net income (loss) to FFO and FFO as adjusted and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.

#### Funds Available for Distribution (“FAD”)

FAD is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired market lease intangibles, net, (ii) amortization of deferred compensation expense, (iii) amortization of deferred financing costs, net, (iv) straight-line rents, (v) non-cash interest and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents) and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD: (i) is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements, and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to CCRC non-refundable entrance fees. Adjustments for unconsolidated joint ventures are calculated to reflect FAD on the same basis. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. FAD does not represent cash generated from operating activities determined in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs, and should not be considered as an alternative to net income (loss) determined in accordance with GAAP. FAD is a non-GAAP supplemental financial measure. For a reconciliation of net income (loss) to FAD and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.

### Comparison of the Three Months Ended June 30, 2016 to the Three Months Ended June 30, 2015 and

### Comparison of the Six Months Ended June 30, 2016 to the Six Months Ended June 30, 2015

### Overview

#### Three Months Ended June 30, 2016 and 2015

The following table summarizes results for the three months ended June 30, 2016 and 2015 (dollars in thousands except per share data):

|  | Three Months Ended June 30, 2016 Amount | Per Share | Three Months Ended June 30, 2015 Amount | Per Share | Per Share Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Net income applicable to common shares** | $301,375 | $0.64 | $164,515 | $0.36 | $0.28 |
| **FFO** | 333,218 | 0.71 | 301,934 | 0.65 | 0.06 |
| **FFO as adjusted** | 347,876 | 0.74 | 365,046 | 0.79 | (0.05) |
| **FAD** | 337,865 | 0.72 | 318,614 | 0.69 | 0.03 |

Earnings per share (“EPS”) increased $0.28 per share primarily as a result of: (i) increased NOI from our 2015 and 2016 acquisitions and SPP growth, excluding our HCRMC DFL investments, (ii) increased gains on sales of real estate due to a higher volume of disposition activities during the second quarter of 2016, (iii) a net termination fee recognized in the second quarter of 2015 not repeated in the second quarter of 2016, (iv) impairment and severance-related charges during the second quarter of 2015 not repeated in the second quarter of 2016, and (v) increased incremental interest income from the payoff of two participating development loans in the second quarter of 2016 compared to the second quarter of 2015. The increase in EPS was partially offset by: (i) a reduction in income from our HCRMC investments as a result of the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016 and a change in income recognition to a cash basis method beginning in January 2016, (ii) a reduction in interest income from placing our investment in Four Seasons senior unsecured notes (“Four Seasons Notes”) on cost recovery status in the third quarter of 2015 (see Note 9 to the Consolidated Financial Statements) and (iii) a reduction of foreign currency remeasurement gains as a result of effective hedges designated in September 2015 (see Note 19 to the Consolidated Financial Statements).

FFO increased $0.06 per share primarily as a result of the aforementioned events impacting EPS offset by gain on sales of real estate, which are excluded from the Company’s calculation of FFO.

FFO as adjusted decreased $0.05 per share primarily as a result of: (i) a reduction in income from our HCRMC investments as a result of the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016 and a change in income recognition to a cash basis method beginning in January 2016 and (ii) a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015. The decrease in FFO as adjusted was partially offset by: (i) increased NOI from our 2015 and 2016 acquisitions and SPP growth, excluding our HCRMC DFL investments, and (ii) increased incremental interest income from the payoff of two participating development loans in the second quarter of 2016 compared to the second quarter of 2015.

FAD increased $0.03 per share primarily as a result of: (i) increased adjusted NOI from our 2015 and 2016 acquisitions and SPP growth and (ii) increased interest income from the payoff of two participating development loans in the second quarter of 2016. The increase in FAD was partially offset by: (i) the reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015, and (ii) increased leasing costs and second generation tenant and capital expenditures.

#### Six Months Ended June 30, 2016 and 2015

The following table summarizes results for the six months ended June 30, 2016 and 2015 (dollars in thousands except per share data):

|  | Six Months Ended June 30, 2016 Amount | Per Share | Six Months Ended June 30, 2015 Amount | Per Share | Per Share Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Net income (loss) applicable to common shares** | $417,185 | $0.89 | $(76,433) | $(0.17) | $1.06 |
| **FFO** | 652,483 | 1.40 | 184,428 | 0.40 | 1.00 |
| **FFO as adjusted** | 669,659 | 1.43 | 729,394 | 1.57 | (0.14) |
| **FAD** | 646,905 | 1.38 | 638,308 | 1.38 | — |

EPS increased $1.06 per share primarily as a result of: (i) increased NOI from our 2015 and 2016 acquisitions and SPP growth, excluding our HCRMC DFL investments, (ii) increased gains on sales of real estate due to a higher volume of disposition activities during 2016, (iii) a net termination fee recognized in the first six months of 2015 not repeated in the first six months of 2016, (iv) impairment and severance-related charges from the first six months of 2015 not repeated in the first six months of 2016 and (v) increased incremental interest income from the payoff of two participating development loans in the second quarter of 2016 compared to the first six months of 2015. The increase in EPS was partially offset by the following: (i) a reduction in income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015, the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016, and a change in income recognition to a cash basis method beginning in January 2016, (ii) increased income tax expense related to our estimated exposure to state built-in gain tax, (iii) a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 (see Note 9 to the Consolidated Financial Statements) and loan repayments during 2015 and 2016, and (v) a reduction of foreign currency remeasurement gains recognized as a result of effective hedges designated in September 2015 (see Note 19 to the Consolidated Financial Statements).

FFO increased $1.00 per share primarily as a result of the aforementioned events impacting EPS offset by gains on sales of real estate, which are excluded from the Company’s calculation of FFO.

FFO as adjusted decreased $0.14 per share primarily as a result of: (i) a reduction in income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015, the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016, and a change in income recognition to a cash basis method beginning in January 2016 and (ii) a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016. The decrease in FFO as adjusted was partially offset by increased: (i) NOI from our 2015 and 2016 acquisitions and SPP growth, excluding our HCRMC DFL investments, and (ii) increase incremental interest income from the payoff of two participating development loans in the second quarter of 2016 compared to the first six months of 2015.

FAD remained consistent for the six months ended June 30, 2016 compared to the six months ended June 30, 2015. For the six months ended June 30, 2016, FAD included: (i) increased adjusted NOI from our 2015 and 2016 acquisitions and SPP growth, (ii) increased incremental interest income from the payoff of two participating development loans in the first six months of 2016 compared to the first six months of 2015, (iii) decreased income from our HCRMC investments discussed above, (iv) decreased interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016, and (v) increased leasing costs and second generation tenant and capital expenditures.

#### Segment Analysis

The tables below provide selected operating information for our SPP and total property portfolio for each of our business segments. Our consolidated SPP for the three months ended June 30, 2016 consists of 1,054 properties representing properties acquired or placed in service and stabilized on or prior to April 1, 2015 and that remained in operation under a consistent reporting structure through June 30, 2016. Our consolidated SPP for the six months ended June 30, 2016 consists of 1,053 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2015 and that remained in operation under a consistent reporting structure through June 30, 2016. Our consolidated total property portfolio consists of 1,159 and 1,184 properties at June 30, 2016 and 2015, respectively.

### Senior Housing

The following table summarizes results as of and for the three months ended June 30, 2016 and 2015 (dollars in thousands except per unit data):

|  | SPP Three Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Three Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $127,078 | $129,215 | $(2,137) | $131,495 | $123,910 | $7,585 |
| Resident fees and services | 110,971 | 105,474 | 5,497 | 164,202 | 106,838 | 57,364 |
| Total segment revenues | 238,049 | 234,689 | 3,360 | 295,697 | 230,748 | 64,949 |
| Operating expenses | (78,615) | (74,815) | (3,800) | (117,121) | (76,514) | (40,607) |
| NOI | 159,434 | 159,874 | (440) | 178,576 | 154,234 | 24,342 |
| Non-cash adjustments to NOI | (2,341) | (6,888) | 4,547 | (2,502) | 1,238 | (3,740) |
| Adjusted NOI | $157,093 | $152,986 | $4,107 | 176,074 | 155,472 | 20,602 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 15,310 | 14,814 | 496 |
| Interest income |  |  |  | 16,474 | 12,237 | 4,237 |
| Portfolio Income |  |  |  | 207,858 | 182,523 | 25,335 |
| Non-SPP adjusted NOI |  |  |  | (50,765) | (29,537) | (21,228) |
| SPP adjusted NOI |  |  |  | $157,093 | $152,986 | $4,107 |
| Adjusted NOI % change |  |  | 2.7% |  |  |  |
| Property count(2) | 447 | 447 |  | 507 | 506 |  |
| Average capacity (units)(3) | 43,989 | 43,907 |  | 50,544 | 45,651 |  |
| Average annual rent per unit(4) | $14,327 | $13,991 |  | $14,064 | $13,734 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended June 30, 2015, we removed eight senior housing properties from SPP that were sold.

(3) Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit for RIDEA properties is based on NOI.

*Portfolio Income.* Our Portfolio Income increased primarily as a result of: (i) additional NOI from our senior housing acquisitions in the second half of 2015 and 2016, primarily from our RIDEA III transaction in June 2015 (see Note 3 to the Consolidated Financial Statements) and (ii) increased incremental interest income from the payoff of two participating development loans resulting from the appreciation of the underlying real estate assets in the second quarter of 2016 compared to the second quarter of 2015.

*SPP.* SPP adjusted NOI improved primarily as a result of annual rent increases and improved performance from RIDEA properties.

The following table summarizes results as of and for the six months ended June 30, 2016 and 2015 (dollars in thousands except per unit data):

|  | SPP Six Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $252,043 | $255,923 | $(3,880) | $260,392 | $251,292 | $9,100 |
| Resident fees and services | 220,110 | 208,810 | 11,300 | 329,965 | 211,851 | 118,114 |
| Total segment revenues | 472,153 | 464,733 | 7,420 | 590,357 | 463,143 | 127,214 |
| Operating expenses | (156,215) | (148,861) | (7,354) | (233,257) | (152,024) | (81,233) |
| NOI | 315,938 | 315,872 | 66 | 357,100 | 311,119 | 45,981 |
| Non-cash adjustments to NOI | (8,115) | (14,421) | 6,306 | (8,458) | (5,175) | (3,283) |
| Adjusted NOI | $307,823 | $301,451 | $6,372 | 348,642 | 305,944 | 42,698 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 30,208 | 28,826 | 1,382 |
| Interest income |  |  |  | 18,359 | 19,631 | (1,272) |
| Portfolio Income |  |  |  | 397,209 | 354,401 | 42,808 |
| Non-SPP adjusted NOI |  |  |  | (89,386) | (52,950) | (36,436) |
| SPP adjusted NOI |  |  |  | $307,823 | $301,451 | $6,372 |
| Adjusted NOI % change |  |  | 2.1% |  |  |  |
| Property count(2) | 446 | 446 |  | 507 | 506 |  |
| Average capacity (units)(3) | 43,902 | 43,907 |  | 50,658 | 45,274 |  |
| Average annual rent per unit(4) | $16,589 | $16,115 |  | $14,612 | $13,610 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the six months ended June 30, 2015, we removed eight senior housing properties from SPP that were sold.

(3) Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit for RIDEA properties is based on NOI.

*Portfolio Income.* Our Portfolio Income increased primarily as a result of: (i) additional NOI from our senior housing acquisitions in the second half of 2015 and first quarter of 2016, primarily from our RIDEA III transaction in June 2015 (see Note 3 to the Consolidated Financial Statements) and (ii) increased incremental interest income from the payoff of two participating development loans resulting from the appreciation of the underlying real estate assets in the second quarter of 2016 compared to the second quarter of 2015, partially offset by decreased interest income from loan repayments during 2015 and 2016.

*SPP.* SPP adjusted NOI improved primarily as a result of annual rent increases and improved performance from RIDEA properties.

### Post-Acute/Skilled Nursing

The following table summarizes results as of and for the three months ended June 30, 2016 and 2015 (dollars in thousands except per bed data):

|  | SPP Three Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Three Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $105,431 | $120,567 | $(15,136) | $110,125 | $130,895 | $(20,770) |
| Operating expenses | (42) | (49) | 7 | (589) | (538) | (51) |
| NOI | 105,389 | 120,518 | (15,129) | 109,536 | 130,357 | (20,821) |
| Non-cash adjustments to NOI | 105 | (18,049) | 18,154 | (173) | (19,077) | 18,904 |
| Adjusted NOI | $105,494 | $102,469 | $3,025 | 109,363 | 111,280 | (1,917) |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 400 | — | 400 |
| Interest income |  |  |  | 16,313 | 23,708 | (7,395) |
| Portfolio Income |  |  |  | 126,076 | 134,988 | (8,912) |
| Non-SPP adjusted NOI |  |  |  | (20,582) | (32,519) | 11,937 |
| SPP adjusted NOI |  |  |  | $105,494 | $102,469 | $3,025 |
| Adjusted NOI % change |  |  | 3.0% |  |  |  |
| Property count(2) | 274 | 274 |  | 296 | 322 |  |
| Average capacity (beds)(3) | 35,098 | 34,099 |  | 37,190 | 39,283 |  |
| Average annual rent per bed | $12,027 | $12,025 |  | $11,825 | $11,385 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended June 30, 2015, we removed 32 post-acute/skilled nursing facilities that were sold and four post-acute/skilled nursing facilities that were deconsolidated as a result of the initial adoption of Accounting Standards Update No. 2015-02, *Amendments to the Consolidation Analysis.*

(3) Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

*Portfolio Income.* Portfolio Income decreased primarily as a result of: (i) a reduction in income from our HCRMC DFL investments as a result of the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016 and a change in income recognition to a cash basis method beginning in 2016 and (ii) a reduction in interest income from placing our Four Seasons Notes on the cost recovery method in the third quarter of 2015.

*SPP.* SPP NOI decreased primarily as a result of a reduction in income from the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016, and a change in income recognition to a cash basis method beginning in 2016, partially offset by annual rent increases on the remaining post-acute/skilled nursing portfolio. SPP adjusted NOI increased as a result of annual rent escalations.

The following table summarizes results as of and for the six months ended June 30, 2016 and 2015 (dollars in thousands except per bed data):

|  | SPP Six Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $207,883 | $252,634 | $(44,751) | $217,315 | $271,471 | $(54,156) |
| Operating expenses | (84) | (95) | 11 | (1,153) | (1,071) | (82) |
| NOI | 207,799 | 252,539 | (44,740) | 216,162 | 270,400 | (54,238) |
| Non-cash adjustments to NOI | 160 | (35,342) | 35,502 | (444) | (37,160) | 36,716 |
| Adjusted NOI | $207,959 | $217,197 | $(9,238) | 215,718 | 233,240 | (17,522) |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 804 | — | 804 |
| Interest income |  |  |  | 32,457 | 49,576 | (17,119) |
| Portfolio Income |  |  |  | 248,979 | 282,816 | (33,837) |
| Non-SPP adjusted NOI |  |  |  | (41,020) | (65,619) | 24,599 |
| SPP adjusted NOI |  |  |  | $207,959 | $217,197 | $(9,238) |
| Adjusted NOI % change |  |  | (4.3)% |  |  |  |
| Property count(2) | 274 | 274 |  | 296 | 322 |  |
| Average capacity (beds)(3) | 35,020 | 34,099 |  | 37,184 | 38,719 |  |
| Average annual rent per bed | $11,880 | $12,744 |  | $11,664 | $12,102 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the six months ended June 30, 2015, we removed 32 post-acute/skilled nursing facilities that were sold and four post-acute/skilled nursing facilities that were deconsolidated as a result of the initial adoption of Accounting Standards Update No. 2015-02, *Amendments to the Consolidation Analysis.*

(3) Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

*Portfolio Income.* Portfolio Income decreased primarily as a result of: (i) a reduction in income from our HCRMC DFL investments as a result of the HCRMC lease amendment effective April 1, 2015, the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016, and a change in income recognition to a cash basis method beginning in 2016 and (ii) a reduction in interest income from placing our Four Seasons Notes on the cost recovery method in the third quarter of 2015.

*SPP.* SPP adjusted NOI decreased primarily as a result of a reduction in income from our HCRMC DFL investments as a result of the HCRMC lease amendment effective April 1, 2015 and the sale of non-strategic assets during the second half of 2015 and the first quarter of 2016, partially offset by annual rent increases on the remaining post-acute/skilled nursing portfolio. Additionally, SPP NOI decreased as a result of a change in income recognition to a cash basis method beginning in 2016 from our HCRMC DFL investments.

### Life Science

The following table summarizes results as of and for the three months ended June 30, 2016 and 2015 (dollars and square feet in thousands except per square foot data):

|  | SPP Three Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Three Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $64,577 | $62,003 | $2,574 | $74,404 | $70,603 | $3,801 |
| Tenant recoveries | 13,914 | 13,371 | 543 | 15,797 | 14,806 | 991 |
| Total segment revenues | 78,491 | 75,374 | 3,117 | 90,201 | 85,409 | 4,792 |
| Operating expenses | (14,898) | (14,692) | (206) | (17,961) | (17,234) | (727) |
| NOI | 63,593 | 60,682 | 2,911 | 72,240 | 68,175 | 4,065 |
| Non-cash adjustments to NOI | 281 | (1,887) | 2,168 | (545) | (2,745) | 2,200 |
| Adjusted NOI | $63,874 | $58,795 | $5,079 | 71,695 | 65,430 | 6,265 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 1,499 | 1,298 | 201 |
| Portfolio Income |  |  |  | 73,194 | 66,728 | 6,466 |
| Non-SPP adjusted NOI |  |  |  | (9,320) | (7,933) | (1,387) |
| SPP adjusted NOI |  |  |  | $63,874 | $58,795 | $5,079 |
| Adjusted NOI % change |  |  | 8.6% |  |  |  |
| Property count(1) | 107 | 107 |  | 113 | 112 |  |
| Average occupancy | 98.4% | 97.0% |  | 98.4% | 97.1% |  |
| Average occupied square feet | 6,735 | 6,639 |  | 7,362 | 7,167 |  |
| Average annual total segment revenues per occupied square foot | $47 | $44 |  | $49 | $46 |  |
| Average annual base rent per occupied square foot | $38 | $36 |  | $40 | $38 |  |

(1) From our past presentation of SPP for the three months ended June 30, 2015, we removed a life science facility that was sold and four life science facilities that were classified as held for sale.

*Portfolio Income.* Portfolio Income increased primarily as a result of increased occupancy, annual rent escalations and additional NOI from our life science acquisitions during 2015.

*SPP.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

During the three months ended June 30, 2016, 566,000 square feet of new and renewal leases commenced at an average annual base rent of $21.64 per square foot compared to 518,000 square feet of expired and terminated leases with an average annual base rent of $19.75 per square foot. During the three months ended June 30, 2016, we disposed of 78,000 square feet with an average annual base rent of $57.18 per square foot.

The following table summarizes results as of and for the six months ended June 30, 2016 and 2015 (dollars and square feet in thousands except per square foot data):

|  | SPP Six Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $128,011 | $122,963 | $5,048 | $148,563 | $140,107 | $8,456 |
| Tenant recoveries | 26,529 | 26,001 | 528 | 30,586 | 28,853 | 1,733 |
| Total segment revenues | 154,540 | 148,964 | 5,576 | 179,149 | 168,960 | 10,189 |
| Operating expenses | (28,460) | (28,710) | 250 | (34,704) | (33,933) | (771) |
| NOI | 126,080 | 120,254 | 5,826 | 144,445 | 135,027 | 9,418 |
| Non-cash adjustments to NOI | 487 | (3,859) | 4,346 | (1,218) | (5,820) | 4,602 |
| Adjusted NOI | $126,567 | $116,395 | $10,172 | 143,227 | 129,207 | 14,020 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 2,919 | 2,526 | 393 |
| Portfolio Income |  |  |  | 146,146 | 131,733 | 14,413 |
| Non-SPP adjusted NOI |  |  |  | (19,579) | (15,338) | (4,241) |
| SPP adjusted NOI |  |  |  | $126,567 | $116,395 | $10,172 |
| Adjusted NOI % change |  |  | 8.7% |  |  |  |
| Property count(1) | 107 | 107 |  | 113 | 112 |  |
| Average occupancy | 98.2% | 96.2% |  | 98.2% | 96.3% |  |
| Average occupied square feet | 6,721 | 6,581 |  | 7,385 | 7,107 |  |
| Average annual total revenues per occupied square foot(1) | $46 | $44 |  | $48 | $46 |  |
| Average annual base rent per occupied square foot | $38 | $36 |  | $40 | $38 |  |

(1) From our past presentation of SPP for the six months ended June 30, 2015, we removed a life science facility that was sold and four life science facilities that were classified as held for sale.

*Portfolio Income.* Portfolio Income increased primarily as a result of increased occupancy, annual rent escalations and the impact of our life science acquisitions during 2015.

*SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

During the six months ended June 30, 2016, 876,000 square feet of new and renewal leases commenced at an average annual base rent of $25.93 per square foot compared to 829,000 square feet of expired and terminated leases with an average annual base rent of $22.43 per square foot. During the six months ended June 30, 2016, we classified 457,000 square feet as real estate and related assets held for sale, net with an average annual base rent of $52.82 per square foot and disposed of 78,000 square feet with an average annual base rent of $57.18 per square foot.

### Medical Office

The following table summarizes results as of and for the three months ended June 30, 2016 and 2015 (dollars and square feet in thousands except per square foot data):

|  | SPP Three Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Three Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $82,528 | $81,322 | $1,206 | $93,791 | $86,654 | $7,137 |
| Tenant recoveries | 16,455 | 15,533 | 922 | 17,427 | 15,931 | 1,496 |
| Total segment revenues | 98,983 | 96,855 | 2,128 | 111,218 | 102,585 | 8,633 |
| Operating expenses | (37,789) | (37,237) | (552) | (43,439) | (40,785) | (2,654) |
| NOI | 61,194 | 59,618 | 1,576 | 67,779 | 61,800 | 5,979 |
| Non-cash adjustments to NOI | 89 | (595) | 684 | (759) | (1,170) | 411 |
| Adjusted NOI | $61,283 | $59,023 | $2,260 | 67,020 | 60,630 | 6,390 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 361 | 306 | 55 |
| Portfolio Income |  |  |  | 67,381 | 60,936 | 6,445 |
| Non-SPP adjusted NOI |  |  |  | (6,098) | (1,913) | (4,185) |
| SPP adjusted NOI |  |  |  | $61,283 | $59,023 | $2,260 |
| Adjusted NOI % change |  |  | 3.8% |  |  |  |
| Property count(1) | 210 | 210 |  | 227 | 228 |  |
| Average occupancy | 90.9% | 90.3% |  | 91.4% | 89.9% |  |
| Average occupied square feet | 13,523 | 13,408 |  | 15,713 | 14,713 |  |
| Average annual total segment revenues per occupied square foot | $29 | $29 |  | $28 | $27 |  |
| Average annual base rent per occupied square foot | $24 | $24 |  | $24 | $23 |  |

(1) From our past presentation of SPP for the three months ended June 30, 2015, we removed three MOBs that were sold.

*Portfolio Income.* Portfolio Income increased primarily as a result of annual rent escalations, increased occupancy and additional NOI from our MOB acquisitions in 2015.

*SPP.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

During the three months ended June 30, 2016, 759,000 square feet of new and renewal leases commenced at an average annual base rent of $23.08 per square foot, including 92,000 square feet related to redevelopments placed into service at an average annual base rent of $28.68, compared to 498,000 square feet of expired and terminated leases with an average annual base rent of $22.37 per square foot. During the three months ended June 30, 2016, we disposed of buildings with 71,000 square feet with an average annual base rent of $26.23 per square foot.

The following table summarizes results as of and for the six months ended June 30, 2016 and 2015 (dollars and square feet in thousands except per square foot data):

|  | SPP Six Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $165,110 | $162,260 | $2,850 | $186,645 | $169,772 | $16,873 |
| Tenant recoveries | 31,772 | 30,624 | 1,148 | 33,567 | 31,118 | 2,449 |
| Total segment revenues | 196,882 | 192,884 | 3,998 | 220,212 | 200,890 | 19,322 |
| Operating expenses | (75,034) | (73,349) | (1,685) | (85,752) | (79,037) | (6,715) |
| NOI | 121,848 | 119,535 | 2,313 | 134,460 | 121,853 | 12,607 |
| Non-cash adjustments to NOI | (373) | (2,228) | 1,855 | (1,564) | (3,036) | 1,472 |
| Adjusted NOI | $121,475 | $117,307 | $4,168 | 132,896 | 118,817 | 14,079 |
| Adjusted NOI from unconsolidated joint ventures |  |  |  | 683 | 610 | 73 |
| Portfolio Income |  |  |  | 133,579 | 119,427 | 14,152 |
| Non-SPP adjusted NOI |  |  |  | (12,104) | (2,120) | (9,984) |
| SPP adjusted NOI |  |  |  | $121,475 | $117,307 | $4,168 |
| Adjusted NOI % change |  |  | 3.6% |  |  |  |
| Property count(1) | 210 | 210 |  | 227 | 228 |  |
| Average occupancy | 90.9% | 90.5% |  | 91.3% | 90.1% |  |
| Average occupied square feet | 13,514 | 13,426 |  | 15,653 | 14,231 |  |
| Average annual total revenues per occupied square foot | $29 | $28 |  | $28 | $28 |  |
| Average annual base rent per occupied square foot | $24 | $24 |  | $23 | $23 |  |

(1) From our past presentation of SPP for the six months ended June 30, 2015, we removed three MOBs that were sold.

*Portfolio Income.* Portfolio Income increased primarily as a result of annual rent escalations, increased occupancy and additional NOI from our MOB acquisitions in 2015.

*SPP.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

During the six months ended June 30, 2016, 1.2 million square feet of new and renewal leases commenced at an average annual base rent of $22.76 per square foot, including 164,000 square feet related to redevelopments placed into service at an average annual base rent of $25.39, compared to 967,000 square feet of expired and terminated leases with an average annual base rent of $23.11 per square foot. During the six months ended June 30, 2016, we disposed of buildings with 71,000 square feet with an average annual base rent of $26.23 per square foot.

### Hospital

The following table summarizes results as of and for the three months ended June 30, 2016 and 2015 (dollars in thousands except per bed data):

|  | SPP Three Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Three Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $21,348 | $20,841 | $507 | $21,361 | $20,853 | $508 |
| Tenant recoveries | 706 | 638 | 68 | 706 | 639 | 67 |
| Total segment revenues | 22,054 | 21,479 | 575 | 22,067 | 21,492 | 575 |
| Operating expenses | (1,015) | (1,271) | 256 | (1,015) | (1,271) | 256 |
| NOI | 21,039 | 20,208 | 831 | 21,052 | 20,221 | 831 |
| Non-cash adjustments to NOI | 582 | 226 | 356 | 582 | 226 | 356 |
| Portfolio Income and Adjusted NOI | $21,621 | $20,434 | $1,187 | 21,634 | 20,447 | 1,187 |
| Non-SPP adjusted NOI |  |  |  | (13) | (13) | — |
| SPP adjusted NOI |  |  |  | $21,621 | $20,434 | $1,187 |
| Adjusted NOI % change |  |  | 5.8% |  |  |  |
| Property count | 16 | 16 |  | 16 | 16 |  |
| Average capacity (beds)(2) | 2,237 | 2,221 |  | 2,237 | 2,221 |  |
| Average annual rent per bed | $40,471 | $39,090 |  | $40,495 | $39,114 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) Represents capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*Portfolio Income and SPP.* Portfolio Income and SPP NOI and adjusted NOI increased primarily as a result of additional variable rents earned in 2016 due to exceeding pre-established thresholds and annual rent escalations.

The following table summarizes results as of and for the six months ended June 30, 2016 and 2015 (dollars in thousands except per bed data):

|  | SPP Six Months Ended June 30, 2016 | 2015 | Change | Total Portfolio Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $43,397 | $42,408 | $989 | $43,423 | $42,433 | $990 |
| Tenant recoveries | 1,514 | 1,300 | 214 | 1,514 | 1,301 | 213 |
| Total segment revenues | 44,911 | 43,708 | 1,203 | 44,937 | 43,734 | 1,203 |
| Operating expenses | (2,214) | (2,308) | 94 | (2,214) | (2,308) | 94 |
| NOI | 42,697 | 41,400 | 1,297 | 42,723 | 41,426 | 1,297 |
| Non-cash adjustments to NOI | 886 | 477 | 409 | 885 | 478 | 407 |
| Portfolio Income and Adjusted NOI | $43,583 | $41,877 | $1,706 | 43,608 | 41,904 | 1,704 |
| Non-SPP adjusted NOI |  |  |  | (25) | (27) | 2 |
| SPP adjusted NOI |  |  |  | $43,583 | $41,877 | $1,706 |
| Adjusted NOI % change |  |  | 4.1% |  |  |  |
| Property count | 16 | 16 |  | 16 | 16 |  |
| Average capacity (beds)(2) | 2,237 | 2,221 |  | 2,237 | 2,221 |  |
| Average annual rent per bed | $40,941 | $39,788 |  | $40,963 | $39,813 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) Represents capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*Portfolio Income and SPP.* Portfolio Income and SPP NOI and adjusted NOI increased primarily as a result of additional variable rents earned in 2016 due to exceeding pre-established thresholds and annual rent escalations.

### Other Income and Expense Items

#### Investment management fee income

Investment management fee income decreased $0.4 million to $0.1 million for the three months ended June 30, 2016. The decrease was primarily the result of the sales of real estate from our unconsolidated joint ventures, HCP Ventures III, LLC and HCP Ventures IV, LLC, in our medical office segment in December 2015 and January 2016.

Investment management fee income decreased $0.7 million to $0.2 million for the six months ended June 30, 2016. The decrease was primarily the result of the sales of real estate from our unconsolidated joint ventures, HCP Ventures III, LLC and HCP Ventures IV, LLC, in our medical office segment in December 2015 and January 2016.

#### Interest expense

Interest expense increased $3 million to $121 million for the three months ended June 30, 2016. The increase was primarily the result of: (i) our senior unsecured notes issuances during 2015 and (ii) increased borrowings under our line of credit facility, partially offset by: (i) repayments of senior unsecured notes during 2015 and 2016 and (ii) mortgage debt that was repaid during 2015 and 2016, primarily in our senior housing segment. The increased borrowings were used to fund our investment activities and to refinance our debt maturities.

The following table sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

| Balance: | As of June 30, (1) 2016 | 2015 |
| --- | ---: | ---: |
| Fixed rate | $9,683,218 | $10,129,635 |
| Variable rate | 1,052,946 | 1,022,324 |
| Total | $10,736,164 | $11,151,959 |
| **Percent of total debt:** |  |  |
| Fixed rate | 90.2% | 90.8% |
| Variable rate | 9.8% | 9.2% |
| Total | 100.0% | 100.0% |
| **Weighted average interest rate at end of period:** |  |  |
| Fixed rate | 4.73% | 4.70% |
| Variable rate | 1.89% | 1.53% |
| Total | 4.45% | 4.41% |

(1) At June 30, 2016 and 2015, excludes $93 million and $95 million, respectively, of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities and demand notes that have no scheduled maturities. At June 30, 2016 and 2015, principal balances of $70 million of variable-rate mortgages are presented as fixed-rate debt as the interest payments were swapped from variable to fixed (see Note 19 to the Consolidated Financial Statements). At June 30, 2016 and 2015, principal balances of £220 million ($295 million) and £357 million ($562 million) of term loans, respectively, are presented as fixed-rate debt as the interest payments were swapped from variable to fixed (see Note 19 to the Consolidated Financial Statements).

Interest expense increased $8 million to $243 million for the six months ended June 30, 2016. The increase was primarily the result of: (i) our senior unsecured notes issuances during 2015 and (ii) increased borrowings under our line of credit facility, partially offset by: (i) repayments of senior unsecured notes during 2015 and 2016 and (ii) mortgage debt that was repaid during 2015 and 2016, primarily in our senior housing segment, and (iii) higher capitalized interest. The increased borrowings were used to fund our investment activities and to refinance our debt maturities.

Our exposure to interest rate fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3 below.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $21 million to $141 million for the three months ended June 30, 2016. The increase was primarily the result of the impact of acquisitions, primarily in our senior housing segment.

Depreciation and amortization expense increased $48 million to $283 million for the six months ended June 30, 2016. The increase was primarily the result of the impact of acquisitions, primarily in our senior housing segment.

#### General and administrative expenses

General and administrative expenses decreased $6 million to $23 million for the three months ended June 30, 2016. The decrease was primarily the result of a $7 million severance-related charge resulting from the resignation of our former Executive Vice President and Chief Investment Officer in June 2015, partially offset by higher professional fees in 2016. We expect to record a severance charge of approximately $14 million in the third quarter of 2016 primarily related to the departure of our former President and Chief Executive Officer in July 2016.

General and administrative expenses decreased $5 million to $48 million for the six months ended June 30, 2016. The decrease was primarily the result of a $7 million severance-related charge resulting from the resignation of our former Executive Vice President and Chief Investment Officer in June 2015, partially offset by higher professional fees in 2016.

#### Acquisition and pursuit costs

Acquisition and pursuit costs decreased $4 million to $15 million for the three months ended June 30, 2016. The decrease was primarily due to lower levels of transactional activity in 2016 compared to the same period in 2015.

Acquisition and pursuit costs decreased $5 million to $17 million for the six months ended June 30, 2016. The decrease was primarily due to lower levels of transactional activity in 2016 compared to the same period in 2015.

We expect that the completion of the Spin-Off will result in a significant increase to acquisition and pursuit costs recognized in 2016.

#### Impairments

During the three months ended June 30, 2015, we recognized an impairment charge of $42 million related to the Four Seasons Notes in our post-acute/skilled nursing segment and $3 million related to a MOB (see Note 9 to the Consolidated Financial Statements). There were no impairment charges recognized in the three months ended June 30, 2016.

During the six months ended June 30, 2015, we recognized the following impairment charges: (i) $478 million related to our HCRMC DFL investments primarily in our post-acute/skilled nursing segment, (ii) $42 million related to our investment in Four Seasons Notes in our post-acute/skilled nursing segment and (iii) $3 million related to a MOB (see Notes 5 and 9 to the Consolidated Financial Statements). There were no impairment charges recognized in the six months ended June 30, 2016.

#### Gain on sales of real estate

During the three and six months ended June 30, 2016, we sold five post-acute/skilled nursing and two senior housing facilities for $130 million, a life science facility for $74 million, two MOBs for $19 million and a senior housing facility for $6 million, recognizing total gain on sales of $120 million.

During the three months ended June 30, 2015, we sold a senior housing facility for $9 million, recognizing gain on sale of $0.1 million. During the six months ended June 30, 2015, we sold nine senior housing facilities for $60 million, recognizing total gain on sales of $6 million.

#### Other income, net

Other income, net decreased $9 million to $2 million for the three months ended June 30, 2016. The decrease was primarily the result of a reduction of foreign currency remeasurement gains from remeasuring assets and liabilities denominated in

GBP to USD as a result of effective hedges designated in September 2015 (see Note 19 to the Consolidated Financial Statements).

Other income, net decreased $9 million to $4 million for the six months ended June 30, 2016. The decrease was primarily the result of reduction of foreign currency remeasurement gains from remeasuring assets and liabilities denominated in GBP to USD as a result of effective hedges designated in September 2015 (see Note 19 to the Consolidated Financial Statements).

#### Income tax benefit (expense)

Income tax benefit decreased $3 million to a $2 million benefit for the three months ended June 30, 2016. During the three months ended June 30, 2015 we acquired U.K. real estate assets, which generated income tax benefits of $2 million. There were no income tax benefits generated from real estate acquisitions during the three months ended June 30, 2016.

Income tax expense increased $56 million to $51 million of expense for the six months ended June 30, 2016. The increase was primarily the result of recognizing tax liabilities of $53 million representing our estimated exposure to state built-in gain tax, of which $49 million is related to our HCRMC DFL investments (see Note 5 to the Consolidated Financial Statements).

#### Equity (loss) income from unconsolidated joint ventures

During the three months ended June 30, 2016, we recognized equity loss from unconsolidated joint ventures of $1 million compared to equity income from unconsolidated joint ventures of $12 million for the three months ended June 30, 2015. The decrease was primarily the result of a change in income recognition on our HCRMC investments to a cash basis method beginning in 2016 within our post-acute/skilled nursing segment.

During the six months ended June 30, 2016, we recognized equity loss from unconsolidated joint ventures of $2 million compared to equity income from unconsolidated joint ventures of $26 million for the six months ended June 30, 2015. The decrease was primarily the result of a change in income recognition on our HCRMC investments to a cash basis method beginning in 2016 within our post-acute/skilled nursing segment.

### Liquidity and Capital Resources

We anticipate: (i) funding recurring operating expenses, (ii) meeting debt service requirements including principal payments and maturities, and (iii) satisfying our distributions to our stockholders and non-controlling interest members, for the next 12 months primarily by using cash flow from operations, available cash balances and cash from our various financing activities.

Our principal investing needs for the next 12 months are to:

- fund capital expenditures, including tenant improvements and leasing costs; and
- fund future acquisition, transactional and development activities.

We anticipate satisfying these future investing needs using one or more of the following:

- issuance of common or preferred stock;
- issuance of additional debt, including unsecured notes and mortgage debt;
- draws on our credit facilities; and/or
- sale or exchange of ownership interests in properties.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of July 29, 2016, we had a credit rating of BBB from Fitch, Baa2 from Moody’s and BBB from S&P Global on our senior unsecured debt securities.

### Cash Flow Summary

The following summary discussion of our cash flows is based on the consolidated statements of cash flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.

Cash and cash equivalents were $116 million and $347 million at June 30, 2016 and December 31, 2015, respectively, representing a decrease of $231 million. The following table sets forth changes in cash flows (in thousands):

|  | Six Months Ended June 30, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: |
| Net cash provided by operating activities | $666,912 | $593,986 | $72,926 |
| Net cash used in investing activities | (153,618) | (1,645,068) | 1,491,450 |
| Net cash (used in) provided by financing activities | (742,748) | 983,042 | (1,725,790) |

The increase in operating cash flow is primarily the result of our 2015 and 2016 acquisitions, annual rent increases and increased working capital. Our cash flow from operations is dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the six months ended June 30, 2016:

- made investments of $472 million (development and acquisition of real estate, and investments in DFLs, unconsolidated joint ventures and loans) and received proceeds of $302 million primarily from real estate and DFL sales;
- paid dividends on common stock of $537 million, which were generally funded by cash provided by our operating activities and cash on hand; and
- raised proceeds of $689 million primarily from our net borrowings under our bank line of credit and repaid $881 million under our bank line of credit, senior unsecured notes and mortgage debt.

### Debt

#### Bank Line of Credit and Term Loans

Our $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends on our credit ratings. We pay a facility fee on the entire revolving commitment that depends on our credit ratings. Based on our credit ratings at July 29, 2016, the margin on the Facility was 1.05%, and the facility fee was 0.20%. The Facility also includes a feature that allows us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At June 30, 2016, we had $869 million, including £275 million ($369 million), outstanding under the Facility with a weighted average effective interest rate of 1.85%.

In July 2016, we exercised a one-year extension option on our 2012 Term Loan. Based on our credit ratings at July 29, 2016, the 2012 Term Loan accrues interest at a rate of GBP LIBOR plus 1.40%. We also have a £220 million ($295 million at June 30, 2016) four-year unsecured term loan that accrues interest at a rate of GBP LIBOR plus 1.15%, subject to adjustments based on the Company’s credit ratings.

The Facility and term loans contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5x. The Facility and term loans also require a Minimum Consolidated Tangible Net Worth of $9.5 billion at June 30, 2016. At June 30, 2016, we were in compliance with each of these restrictions and requirements.

#### Senior Unsecured Notes

At June 30, 2016, we had senior unsecured notes outstanding with an aggregate principal balance of $8.7 billion. Effective interest rates on the notes ranged from 2.79% to 6.88% with a weighted average effective interest rate of 4.72% and a weighted average maturity of six years at June 30, 2016. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at June 30, 2016.

#### Mortgage Debt

At June 30, 2016, we had mortgage debt outstanding with an aggregate principal balance of $688 million, which is secured by 40 healthcare facilities (including redevelopment properties) with a carrying value of $944 billion. Effective interest rates on the mortgage debt ranged from 3.08% to 8.23% with a weighted average effective interest rate of 6.06% and a weighted average maturity of three years at June 30, 2016.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets, and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

### Equity

At June 30, 2016, we had 467 million shares of common stock outstanding, equity totaled $9.7 billion, and our equity securities had a market value of $16.7 billion.

At June 30, 2016, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

#### At-The-Market Program

In June 2015, we established an At-The-Market Program, in connection with the renewal of our Shelf Registration Statement. Under this program, we may sell shares of our common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. There was no activity during the six months ended June 30, 2016 and, as of June 30, 2016, shares of our common stock having an aggregate gross sales price of $676 million were available for sale under the At-The-Market Program. Actual future sales will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock and our capital needs. We have no obligation to sell the remaining shares available for sale under our program.

#### Shelf Registration

We filed a prospectus with the SEC as part of a registration statement on Form S-3ASR, using a shelf registration process, which expires in June 2018. Under the “shelf” process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

#### Capital Market Outlook

The capital markets have facilitated our continued growth, including our international expansion. For the 18 months ended June 30, 2016, we have raised $2.0 billion in senior unsecured notes and originated a £220 million ($333 million) four-year unsecured term loan. The capital raised, in combination with available cash and borrowing capacity under our Facility, supported $2.5 billion of investments completed during the 18 months ended June 30, 2016. We believe our equity and debt investors, as well as our banking relationships, will provide additional capital as we pursue new investment opportunities.

### Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at June 30, 2016 (in thousands):

|  | Total(1) | Less than One Year | 2017-2018 | 2019-2020 | More than Five Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Bank line of credit(2) | $869,078 | $— | $869,078 | $— | $— |
| Term loans(3) | 479,130 | — | 183,868 | 295,262 | — |
| Senior unsecured notes | 8,700,000 | 400,000 | 1,350,000 | 1,250,000 | 5,700,000 |
| Mortgage debt | 687,956 | 34,240 | 588,474 | 4,150 | 61,092 |
| U.K. loan commitments(4) | 53,184 | 40,265 | 12,919 | — | — |
| Construction loan commitments(5) | 815 | 815 | — | — | — |
| Development commitments(6) | 123,281 | 88,524 | 32,597 | 2,160 | — |
| Ground and other operating leases | 411,052 | 3,932 | 14,542 | 14,217 | 378,361 |
| Interest(7) | 2,551,793 | 231,684 | 727,563 | 543,451 | 1,049,095 |
| Total(8) | $13,876,289 | $799,460 | $3,779,041 | $2,109,240 | $7,188,548 |

(1) Excludes $93 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities and $100 million of Capital Addition Financing (as defined in the amended master lease with HCRMC) for which the timing and amount of payments are uncertain.

(2) Includes £275 million ($369 million) translated to USD.

(3) Represents £357 million translated to USD. Reflects a one-year extension option on the 2012 Term Loan that was exercised in July 2016.

(4) Represents £40 million translated to USD for commitments to fund our U.K. loan facilities.

(5) Represents commitments to finance development projects and related working capital financings.

(6) Represents construction and other commitments for developments in progress.

(7) Interest on variable-rate debt is calculated using rates in effect at June 30, 2016.

(8) Excludes the HCRMC Capital Additions Costs (as defined in the master lease with HCRMC) as the timing and amount of payments are uncertain.

### Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described in Note 7 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable (see Note 16 to the Consolidated Financial Statements). In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described above under “Contractual Obligations.”

### Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the tenant or operator to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the tenant or operator expense reimbursements and contractual rent increases described above.

### Non-GAAP Financial Measures Reconciliations

The following is a reconciliation from net income applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD (in thousands, except per share data):

|  | Three Months Ended June 30, 2016 | 2015 | Six Months Ended June 30, 2016 | 2015 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) applicable to common shares | $301,375 | $164,515 | $417,185 | $(76,433) |
| Depreciation and amortization | 141,386 | 120,403 | 282,708 | 234,925 |
| Other depreciation and amortization | 2,974 | 5,128 | 5,936 | 11,812 |
| Gain on sales of real estate | (119,614) | (61) | (119,614) | (6,325) |
| Taxes associated with real estate disposition | — | — | 53,177 | — |
| Impairments of real estate | — | 2,948 | — | 2,948 |
| Equity loss (income) from unconsolidated joint ventures | 1,067 | (12,001) | 1,975 | (25,602) |
| FFO from unconsolidated joint ventures | 11,172 | 23,943 | 21,550 | 48,792 |
| Noncontrolling interests’ and participating securities’ share in earnings | 3,467 | 3,233 | 7,402 | 6,678 |
| Noncontrolling interests’ and participating securities’ share in FFO | (8,609) | (6,174) | (17,836) | (12,367) |
| FFO applicable to common shares | 333,218 | 301,934 | 652,483 | 184,428 |
| Distributions on dilutive convertible units | 3,525 | 3,568 | 7,109 | — |
| Diluted FFO applicable to common shares | $336,743 | $305,502 | $659,592 | $184,428 |
| Diluted FFO per common share | $0.71 | $0.65 | $1.40 | $0.40 |
| Weighted average shares used to calculate diluted FFO per common share | 473,149 | 468,115 | 472,667 | 461,649 |

| Impact of adjustments to FFO: |  |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| Other impairments(1) | $— | $41,887 | $— | $520,351 |
| Transaction-related items and other | 14,658 | 24,045 | 17,176 | 27,435 |
| Severance-related charge(2) | — | 6,713 |  | 6,713 |
| Foreign currency remeasurement gains | — | (9,533) | — | (9,533) |
|  | $14,658 | $63,112 | $17,176 | $544,966 |
| FFO as adjusted applicable to common shares | $347,876 | $365,046 | $669,659 | $729,394 |
| Distributions on dilutive convertible units and other | 3,503 | 3,474 | 7,083 | 6,793 |
| Diluted FFO as adjusted applicable to common shares | $351,379 | $368,520 | $676,742 | $736,187 |
| Diluted FFO as adjusted per common share | $0.74 | $0.79 | $1.43 | $1.57 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 473,149 | 468,115 | 472,667 | 467,675 |

63

|  | Three Months Ended June 30, 2016 | 2015 | Six Months Ended June 30, 2016 | 2015 |
| --- | ---: | ---: | ---: | ---: |
| FFO as adjusted applicable to common shares | $347,876 | $365,046 | $669,659 | $729,394 |
| Amortization of market lease intangibles, net | (503) | (258) | (972) | (636) |
| Amortization of deferred compensation(3) | 4,160 | 6,665 | 9,505 | 12,830 |
| Amortization of deferred financing costs | 5,281 | 4,974 | 10,561 | 9,726 |
| Straight-line rents | (3,541) | (8,202) | (11,117) | (17,748) |
| DFL non-cash interest(4) | 666 | (21,210) | 1,330 | (41,514) |
| Other depreciation and amortization | (2,974) | (5,128) | (5,935) | (11,812) |
| Deferred revenues – tenant improvement related | (515) | (647) | (992) | (1,391) |
| Deferred revenues – additional rents | 326 | 545 | 184 | 387 |
| Leasing costs and tenant and capital improvements | (20,761) | (16,127) | (40,052) | (27,667) |
| Lease restructure payments | 6,318 | 5,166 | 12,612 | 10,301 |
| Joint venture adjustments – CCRC entrance fees | 8,057 | 7,469 | 15,223 | 13,662 |
| Joint venture and other FAD adjustments(4) | (6,525) | (19,679) | (13,101) | (37,224) |
| FAD applicable to common shares | $337,865 | $318,614 | $646,905 | $638,308 |
| Distributions on dilutive convertible units | 3,525 | 3,568 | 7,109 | 7,136 |
| Diluted FAD applicable to common shares | $341,390 | $322,182 | $654,014 | $645,444 |
| Diluted FAD per common share | $0.72 | $0.69 | $1.38 | $1.38 |
| Weighted average shares used to calculate diluted FAD per common share | 473,149 | 468,115 | 472,667 | 467,675 |

64

The following is a reconciliation, on a per share basis, from net income (loss) applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD:

|  | Three Months Ended June 30, 2016 | 2015 | Six Months Ended June 30, 2016 | 2015 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) applicable to common shares | $0.64 | $0.36 | $0.89 | $(0.17) |
| Depreciation and amortization | 0.30 | 0.26 | 0.61 | 0.51 |
| Other depreciation and amortization | 0.01 | 0.01 | 0.01 | 0.03 |
| Taxes related to real estate disposition and gain on sales of real estate | (0.25) | — | (0.14) | (0.01) |
| Joint venture and participating securities FFO adjustments | 0.01 | 0.02 | 0.03 | 0.04 |
| Diluted FFO applicable to common shares | $0.71 | $0.65 | $1.40 | $0.40 |
| Other impairments(1) | — | 0.09 | — | 1.12 |
| Transaction-related items and other | 0.03 | 0.05 | 0.03 | 0.06 |
| Severance-related charge(2) | — | 0.02 | — | 0.01 |
| Foreign currency remeasurement gains | — | (0.02) | — | (0.02) |
| FFO as adjusted applicable to common shares | $0.74 | $0.79 | $1.43 | $1.57 |
| Amortization of market lease intangibles, net, straight-line rents and deferred revenues | (0.01) | (0.02) | (0.03) | (0.04) |
| Amortization of deferred compensation(3) | 0.01 | 0.01 | 0.02 | 0.03 |
| Amortization of deferred financing costs | 0.01 | 0.01 | 0.02 | 0.02 |
| DFL non-cash interest(4) | — | (0.05) | — | (0.09) |
| Other depreciation and amortization | (0.01) | (0.01) | (0.01) | (0.02) |
| Leasing costs and tenant and capital improvements | (0.04) | (0.03) | (0.08) | (0.06) |
| Lease restructure payments | 0.01 | 0.01 | 0.03 | 0.02 |
| Joint venture adjustments – CCRC entrance fees | 0.02 | 0.02 | 0.03 | 0.03 |
| Joint venture and other FAD adjustments(4) | (0.01) | (0.04) | (0.03) | (0.08) |
| FAD applicable to common shares | $0.72 | $0.69 | $1.38 | $1.38 |

(1) For the three months ended June 30, 2015, the other impairment is related to our Four Seasons Notes. For the six months ended June 30, 2015, other impairments include: (i) $42 million related to our Four Seasons Notes and (ii) $478 million related to our HCRMC DFL investments.

(2) The severance-related charge relates to the resignation of our former Executive Vice President and Chief Investment Officer.

(3) Excludes $3 million related to the acceleration of deferred compensation for restricted stock units and stock options that vested upon the resignation of our former Executive Vice President and Chief Investment Officer, which is included in the severance-related charge for the three and six months ended June 30, 2015.

(4) Our equity investment in HCRMC is accounted for using the equity method, which requires an elimination of DFL income that is proportional to our ownership in HCRMC. Further, our share of earnings from HCRMC (equity income) increases for the corresponding elimination of related lease expense recognized at the HCRMC entity level, which we present as a non-cash joint venture FAD adjustment. Beginning in January 2016, equity income is recognized only if cash distributions are received from HCRMC. As a result, we no longer eliminate our proportional ownership share of income from DFLs to equity income (loss) from unconsolidated joint ventures for our equity investment in HCRMC.

### Critical Accounting Policies

The preparation of financial statements in conformity with GAAP requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2015 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Note 2 to the Consolidated Financial Statements. Our critical accounting policies have not changed during 2016.

### Recent Accounting Pronouncements

See Note 2 to the Consolidated Financial Statements for the impact of new accounting standards.

## Market risk

As filed, 4,080 characters.

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates, specifically the GBP. We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the consolidated balance sheets at fair value (see Note 19 to the Consolidated Financial Statements).

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $5 million (see Note 19 to the Consolidated Financial Statements).

*Interest Rate Risk.* At June 30, 2016, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate debt, which has been predominately hedged through interest-rate swap contracts.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could adversely be affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate debt and variable-rate investments, and assuming no other changes in the outstanding balance as of June 30, 2016, our annual interest expense would increase by approximately $9 million, or $0.02 per common share on a diluted basis.

*Foreign Currency Risk.* At June 30, 2016, our exposure to foreign currencies primarily relates to U.K. investments in leased real estate, senior notes and related GBP denominated cash flows. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts. Based solely on our operating results for the three months ended June 30, 2016, including the impact of existing hedging arrangements, if the value of the GBP relative to the USD were to increase or decrease by 10% compared to the average exchange rate during the quarter ended June 30, 2016, our cash flows would have decreased or increased, as applicable, by less than $1 million.

*Market Risk.* We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At June 30, 2016, both the fair value and carrying value of marketable debt securities was $84 million.

## Controls and procedures

As filed, 2,062 characters.

*Disclosure Controls and Procedures.* We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2016. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2016.

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting (as such term as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 267 characters.

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2015, as updated by Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2016.

Filed Aug 9, 2016.
Source: SEC EDGAR, the filing index for accession 0001558370-16-007721. Last ingested by Listed: Nov 14, 2026, 21:09 ET. No prices; not investment advice.
